Rock Springs Capital Management LP - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$71,780,607
-0.9%
1,419,150
-8.5%
1.92%
+11.6%
Q2 2023$72,404,704
+30.1%
1,550,754
+6.6%
1.72%
+29.7%
Q1 2023$55,639,758
-27.5%
1,454,254
+3.8%
1.33%
-28.1%
Q4 2022$76,755,839
+64.5%
1,400,654
+2.2%
1.85%
+53.3%
Q3 2022$46,648,000
+626.5%
1,369,973
+101.6%
1.20%
+544.4%
Q2 2022$6,421,000
-28.8%
679,514
+7.0%
0.19%
-17.6%
Q1 2022$9,014,000
-27.4%
635,214
+8.2%
0.23%
-20.9%
Q4 2021$12,417,000
-2.3%
587,101
+3.2%
0.29%
+7.5%
Q3 2021$12,710,000
-3.1%
568,701
+7.6%
0.27%
+3.1%
Q2 2021$13,115,000
-13.3%
528,601
+1.4%
0.26%
-21.5%
Q1 2021$15,119,000
+13.7%
521,171
+1.1%
0.33%
+17.0%
Q4 2020$13,297,000
+2.1%
515,371
+21.8%
0.28%
-14.5%
Q3 2020$13,025,000
+115.1%
423,040
+74.1%
0.33%
+98.8%
Q2 2020$6,055,000
+26.9%
242,985
+8.0%
0.17%
-15.7%
Q1 2020$4,770,000
-4.5%
225,0000.0%0.20%
+24.7%
Q4 2019$4,994,000
-2.4%
225,0000.0%0.16%
-22.5%
Q3 2019$5,119,000
+18.8%
225,0000.0%0.20%
+30.8%
Q2 2019$4,309,000225,0000.16%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders